Report Overview
Report Summary
Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Docetaxel market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Docetaxel market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
Key Research Highlights: Market Drivers
The Docetaxel market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Docetaxel products across developed and developing countries of the world.
Key Research Highlights: Market Restrains
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Docetaxel products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Docetaxel market.
To learn more about this report
Key Research Highlights: Trends
Increasing research and development spending on Docetaxel development has been the leading industry trend of Docetaxel market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
Global Docetaxel Market Size, 2018-2028 (USD MILLION)
To learn more about this report
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report Coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments Covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
40 mg/ml,20 mg/ml,10 mg/ml, Other |
| By Application Outlook |
Breast Cancer, Non-Small Cell Lung Cancer, Prostate Cancer, Gastric Adenocarcinoma Cancer, Head And Neck Cancer |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Dr. Reddy, Celon Laboratories, Fresenius Kabi India, VHB Life Sciences, Sanofi,Sun Pharma, RPG Life Sciences, Natco, Cipla, Samarth life sciences |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Market Players
- Dr. Reddy
- Celon Laboratories
- Fresenius Kabi India
- VHB Life Sciences
- Sanofi
- Sun Pharma
- RPG Life Sciences
- Natco
- Cipla
- Samarth life sciences
Docetaxel Market, By Type
- 40 mg/ml
- 20 mg/ml
- 10 mg/ml
- Other
Docetaxel Market, By Application
- Breast cancer
- Non-small cell lung cancer
- Prostate cancer
- Gastric adenocarcinoma cancer
- Head and neck cancer
Key Benefits To The Stake Holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Table Of Contents
Table Of Contents
Table of Contents
Global Docetaxel Market Report 2020, Forecast to 2027
1 Scope of the Study
1.1 Docetaxel Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives
2 Docetaxel Industry Overview
2.1 Global Docetaxel Market Size (Million USD) Comparison by Regions (2020-2027)
2.1.1 Docetaxel Global Import Market Analysis
2.1.2 Docetaxel Global Export Market Analysis
2.1.3 Docetaxel Global Main Region Market Analysis
2.2 Market Analysis by Type
2.2.1 40 mg/ml
2.2.2 20 mg/ml
2.2.3 10 mg/ml
2.3.2 Non-small cell lung cancer
2.3.3 Prostate cancer
2.3.4 Gastric adenocarcinoma cancer
2.3.5 Head and neck cancer
2.4.2 Global Docetaxel Revenue and Market Share by Manufacturer (2018-2020)
2.4.3 Global Docetaxel Industry Concentration Ratio (CR5 and HHI)
2.4.4 Top 5 Docetaxel Manufacturer Market Share
2.4.5 Top 10 Docetaxel Manufacturer Market Share
2.4.6 Date of Key Manufacturers Enter into Docetaxel Market
2.4.7 Key Manufacturers Docetaxel Product Offered
2.4.8 Mergers & Acquisitions Planning
2.5 Docetaxel Historical Development Overview
2.6 Market Dynamics
2.6.1 Market Opportunities
2.6.2 Market Risk
2.6.3 Market Driving Force
2.6.4 Porter's Five Forces Analysis
3 Upstream and Downstream Market Analysis
3.1 Upstream Analysis
3.1.1 Macro Analysis of Upstream Markets
3.1.2 Key Players in Upstream Markets
3.1.3 Upstream Market Trend Analysis
3.1.4 Docetaxel Manufacturing Cost Analysis
3.2 Downstream Market Analysis
3.2.1 Macro Analysis of Down Markets
3.2.2 Key Players in Down Markets
3.2.3 Downstream Market Trend Analysis
3.2.4 Sales Channel, Distributors, Traders and Dealers
4 Global Docetaxel Market Size Categorized by Regions
4.1 Global Docetaxel Revenue, Sales and Market Share by Regions
4.1.1 Global Docetaxel Sales and Market Share by Regions (2015-2020)
4.1.2 Global Docetaxel Revenue and Market Share by Regions (2015-2020)
4.2 Europe Docetaxel Sales and Growth Rate (2015-2020)
4.3 APAC Docetaxel Sales and Growth Rate (2015-2020)
4.4 North America Docetaxel Sales and Growth Rate (2015-2020)
4.5 South America Docetaxel Sales and Growth Rate (2015-2020)
4.6 Middle East & Africa Docetaxel Sales and Growth Rate (2015-2020)
5 Europe Docetaxel Market Size Categorized by Countries
5.1 Europe Docetaxel Sales, Revenue and Market Share by Countries
5.1.1 Europe Docetaxel Sales by Countries (2015-2020)
5.1.2 Europe Docetaxel Revenue by Countries (2015-2020)
5.1.3 Germany Docetaxel Sales and Growth Rate (2015-2020)
5.1.4 UK Docetaxel Sales and Growth Rate (2015-2020)
5.1.5 France Docetaxel Sales and Growth Rate (2015-2020)
5.1.6 Russia Docetaxel Sales and Growth Rate (2015-2020)
5.1.7 Italy Docetaxel Sales and Growth Rate (2015-2020)
5.1.8 Spain Docetaxel Sales and Growth Rate (2015-2020)
5.2 Europe Docetaxel Revenue (Value) by Manufacturers (2018-2020)
5.3 Europe Docetaxel Sales, Revenue and Market Share by Type (2015-2020)
5.3.1 Europe Docetaxel Sales Market Share by Type (2015-2020)
5.3.2 Europe Docetaxel Revenue and Revenue Share by Type (2015-2020)
5.4 Europe Docetaxel Sales Market Share by Application (2015-2020)
6 Asia-Pacific Docetaxel Market Size Categorized by Countries
6.1 Asia-Pacific Docetaxel Sales, Revenue and Market Share by Countries
6.1.1 Asia-Pacific Docetaxel Sales by Countries (2015-2020)
6.1.2 Asia-Pacific Docetaxel Revenue by Countries (2015-2020)
6.1.3 China Docetaxel Sales and Growth Rate (2015-2020)
6.1.4 Japan Docetaxel Sales and Growth Rate (2015-2020)
6.1.5 Korea Docetaxel Sales and Growth Rate (2015-2020)
6.1.6 India Docetaxel Sales and Growth Rate (2015-2020)
6.1.7 Southeast Asia Docetaxel Sales and Growth Rate (2015-2020)
6.1.8 Australia Docetaxel Sales and Growth Rate (2015-2020)
6.2 Asia-Pacific Docetaxel Sales and Revenue (Value) by Manufacturers (2018-2020)
6.3 Asia-Pacific Docetaxel Sales, Revenue and Market Share by Type (2015-2020)
6.3.1 Asia-Pacific Docetaxel Sales Market Share by Type (2015-2020)
6.3.2 Asia-Pacific Docetaxel Revenue and Revenue Share by Type (2015-2020)
6.4 Asia-Pacific Docetaxel Sales and Market Share by Application (2015-2020)
7 North America Docetaxel Market Size Categorized by Countries
7.1 North America Docetaxel Sales, Revenue and Market Share by Countries
7.1.1 North America Docetaxel Sales by Countries (2015-2020)
7.1.2 North America Docetaxel Revenue by Countries (2015-2020)
7.1.3 United States Docetaxel Sales and Growth Rate (2015-2020)
7.1.4 Canada Docetaxel Sales and Growth Rate (2015-2020)
7.1.5 Mexico Docetaxel Sales and Growth Rate (2015-2020)
7.2 North America Docetaxel Revenue (Value) by Manufacturers (2018-2020)
7.3 North America Docetaxel Sales, Revenue and Market Share by Type (2015-2020)
7.3.1 North America Docetaxel Sales Market Share by Type (2015-2020)
7.3.2 North America Docetaxel Revenue and Revenue Share by Type (2015-2020)
7.4 North America Docetaxel Sales Market Share by Application (2015-2020)
8 South America Docetaxel Market Size Categorized by Countries
8.1 South America Docetaxel Sales, Revenue and Market Share by Countries
8.1.1 South America Docetaxel Sales by Countries (2015-2020)
8.1.2 South America Docetaxel Revenue by Countries (2015-2020)
8.1.3 Brazil Docetaxel Sales and Growth Rate (2015-2020)
8.2 South America Docetaxel Revenue (Value) by Manufacturers (2018-2020)
8.3 South America Docetaxel Sales, Revenue and Market Share by Type (2015-2020)
8.3.1 South America Docetaxel Sales Market Share by Type (2015-2020)
8.3.2 South America Docetaxel Revenue and Revenue Share by Type (2015-2020)
8.4 South America Docetaxel Sales Market Share by Application (2015-2020)
9 Middle East and Africa Docetaxel Market Size Categorized by Countries
9.1 Middle East and Africa Docetaxel Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Docetaxel Sales by Countries (2015-2020)
9.1.2 Middle East and Africa Docetaxel Revenue by Countries (2015-2020)
9.1.3 GCC Countries Docetaxel Sales and Growth Rate (2015-2020)
9.1.4 Turkey Docetaxel Sales and Growth Rate (2015-2020)
9.1.5 Egypt Docetaxel Sales and Growth Rate (2015-2020)
9.1.6 South Africa Docetaxel Sales and Growth Rate (2015-2020)
9.2 Middle East and Africa Docetaxel Revenue (Value) by Manufacturers (2018-2020)
9.3 Middle East and Africa Docetaxel Sales, Revenue and Market Share by Type
9.3.1 Middle East and Africa Docetaxel Sales Market Share by Type (2015-2020)
9.3.2 Middle East and Africa Docetaxel Revenue and Revenue Share by Type (2015-2020)
9.4 Middle East and Africa Docetaxel Sales Market Share by Application (2015-2020)
10 Global Docetaxel Market Segment by Type
10.1 Global Docetaxel Revenue, Sales and Market Share by Type (2015-2020)
10.1.1 Global Docetaxel Sales and Market Share by Type (2015-2020)
10.1.2 Global Docetaxel Revenue and Market Share by Type (2015-2020)
10.2 40 mg/ml Sales Growth Rate and Price
10.2.1 Global 40 mg/ml Sales Growth Rate (2015-2020)
10.2.2 Global 40 mg/ml Price (2015-2020)
10.3 20 mg/ml Sales Growth Rate and Price
10.3.1 Global 20 mg/ml Sales Growth Rate (2015-2020)
10.3.2 Global 20 mg/ml Price (2015-2020)
10.4 10 mg/ml Sales Growth Rate and Price
10.4.1 Global 10 mg/ml Sales Growth Rate (2015-2020)
10.4.2 Global 10 mg/ml Price (2015-2020)
11.1 Global DocetaxelSales Market Share by Application (2015-2020)
11.2 Breast cancer Sales Growth Rate (2015-2020)
11.3 Non-small cell lung cancer Sales Growth Rate (2015-2020)
11.4 Prostate cancer Sales Growth Rate (2015-2020)
11.5 Gastric adenocarcinoma cancer Sales Growth Rate (2015-2020)
11.6 Head and neck cancer Sales Growth Rate (2015-2020)
12.1 Global Docetaxel Revenue, Sales and Growth Rate (2020-2027)
12.2 Docetaxel Market Forecast by Regions (2020-2027)
12.2.1 Europe Docetaxel Market Forecast (2020-2027)
12.2.2 APAC Docetaxel Market Forecast (2020-2027)
12.2.3 North America Docetaxel Market Forecast (2020-2027)
12.2.4 South America Docetaxel Market Forecast (2020-2027)
12.2.5 Middle East & Africa Docetaxel Market Forecast (2020-2027)
12.3 Docetaxel Market Forecast by Type (2020-2027)
12.3.1 Global Docetaxel Sales Forecast by Type (2020-2027)
12.3.2 Global Docetaxel Market Share Forecast by Type (2020-2027)
12.4 Docetaxel Market Forecast by Application (2020-2027)
12.4.1 Global Docetaxel Sales Forecast by Application (2020-2027)
12.4.2 Global Docetaxel Market Share Forecast by Application (2020-2027)
13 Analysis of Docetaxel Industry Key Manufacturers
13.1 Dr. Reddy
13.1.1 Company Details
13.1.2 Product Information
13.1.3 Dr. Reddy Docetaxel Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.1.4 Main Business Overview
13.1.5 Dr. Reddy News
13.2 Celon Laboratories
13.2.1 Company Details
13.2.2 Product Information
13.2.3 Celon Laboratories Docetaxel Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.2.4 Main Business Overview
13.2.5 Celon Laboratories News
13.3 Fresenius Kabi India
13.3.1 Company Details
13.3.2 Product Information
13.3.3 Fresenius Kabi India Docetaxel Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.3.4 Main Business Overview
13.3.5 Fresenius Kabi India News
13.4 VHB Life Sciences
13.4.1 Company Details
13.4.2 Product Information
13.4.3 VHB Life Sciences Docetaxel Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.4.4 Main Business Overview
13.4.5 VHB Life Sciences News
13.5 Sanofi
13.5.1 Company Details
13.5.2 Product Information
13.5.3 Sanofi Docetaxel Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.5.4 Main Business Overview
13.5.5 Sanofi News
13.6 Sun Pharma
13.6.1 Company Details
13.6.2 Product Information
13.6.3 Sun Pharma Docetaxel Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.6.4 Main Business Overview
13.6.5 Sun Pharma News
13.7 RPG Life Sciences
13.7.1 Company Details
13.7.2 Product Information
13.7.3 RPG Life Sciences Docetaxel Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.7.4 Main Business Overview
13.7.5 RPG Life Sciences News
13.8 Natco
13.8.1 Company Details
13.8.2 Product Information
13.8.3 Natco Docetaxel Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.8.4 Main Business Overview
13.8.5 Natco News
13.9 Cipla
13.9.1 Company Details
13.9.2 Product Information
13.9.3 Cipla Docetaxel Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.9.4 Main Business Overview
13.9.5 Cipla News
13.10 Samarth life sciences
13.10.1 Company Details
13.10.2 Product Information
13.10.3 Samarth life sciences Docetaxel Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.10.4 Main Business Overview
13.10.5 Samarth life sciences News
15 Appendix